Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

In 2021, liver disease led to 2.7 million emergency department (ED) visits in the U.S., 2 million hospitalizations, and ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...

(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S ...

MASH has long been a challenging and progressive liver disease, characterized by fat build-up and inflammation that, if left ...

Dr. Jennifer Flemming said there is an “urgent need” to identify risk groups and intervene with treatment and disease management Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has ...

Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is gone, and this“residual diseas ...

Universal Music Group has filed a scathing motion to dismiss Drake‘s New York lawsuit against them for promoting Kendrick Lamar‘s “Not Like Us,” stating that he’s only suing because he ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity, but GLP-1 competition from Novo and Lilly poses significant future challenges.